Ole Jannik Bjerrum

Ole Jannik Bjerrum

Professor, emeritus


  1. Published

    A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and Commentary

    Borup, G., Bach, K. F., Schmiegelow, M., Kildemoes, H. W., Bjerrum, Ole Jannik & Westergaard, N., May 2016, In: Therapeutic Innovation & Regulatory Science. 50, 3, p. 304-311 8 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Published

    A novel inhibitor of advanced glycation end- product formation inhibits mesenteric vascular hypertrophy in experimental diabetes

    Bjerrum, Ole Jannik, 1999, In: Diabetologica. 42, p. 472-479 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A simple method for the preparation and purification of C1 complement cleaved beta 2-microglobulin from human serum.

    Nissen, Mogens Holst, Johansen, B. & Bjerrum, Ole Jannik, 1997, In: Journal of Immunological Methods. 205, 1, p. 29-33 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Alleviation of nociception in rats by treatment with ceftriaxone, a ß-lactam that promote the expression of the excitatory amino acid transporter 2

    Bjerrum, Ole Jannik, Abrahamsen, B. & Honoré, P. G. H., Nov 2011.

    Research output: Contribution to conferencePosterCommunication

  5. Published

    An analysis of the fixed-dose combinations authorized by the European Union, 2009-14: A Focus on benefit-risk and clinial development condition

    Sawicki-Wrzask, D., Thomsen, M. & Bjerrum, Ole Jannik, 2015, In: Therapeutic Innovation & Regulatory Science. 49, 4, p. 553-559 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA's and FDA's Views on Initial Dual-Therapy

    Bjerrum, Ole Jannik, Eichendorff, S. & Alkis, N. B., Mar 2020, In: Therapeutic Innovation & Regulatory Science. 54, 2, p. 297-302 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy

    Bjerrum, Ole Jannik, Eichendorff, S. & Alkis, N. B., 2019, In: Therapeutic Innovation & Regulatory Science. 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Beta-lactam antibiotic as dose dependent analgesic treatment of neuropathic pain

    Bjerrum, Ole Jannik, Abrahamsen, B. & Honoré, P. G. H., 2011.

    Research output: Contribution to conferencePosterResearchpeer-review

  9. Published

    Bivirkningsmonitorering af lægemidler: en ny udfordring af apoteksfarmaceuter

    Christensen, S. T. & Bjerrum, Ole Jannik, 2009, In: Lægemiddelforskning. p. 49-51

    Research output: Contribution to journalJournal articleCommunication

  10. Published

    Blå medicin mod smerter

    Boulakou, A., Bjerrum, Ole Jannik & Honoré, P. G. H., 2012, In: Lægemiddelforskning. 2012, p. 18-19 2 p.

    Research output: Contribution to journalJournal articleCommunication

  11. Published

    Body of evidence and approaches applied in the clinical development programme of fixed-dose combinations in the European Union from 2010 to 2016

    Nøhr-Nielsen, A., De Bruin, M. L., Thomsen, M., Pipper, C. B., Lange, Theis, Bjerrum, Ole Jannik & Lund, Trine Meldgaard, 2019, In: British Journal of Clinical Pharmacology. 85, 8, p. 1829-1840 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Ceftriaxone, an EAAT-2 transporter inducer, shows antinociceptive effects in acute and neuropathic pain models

    Bjerrum, Ole Jannik, Abrahamsen, B. & Honoré, P. G. H., 2011.

    Research output: Contribution to conferencePosterResearchpeer-review

  13. Published

    Centrally mediated anti-noceptive action of GABAA receptor agonists in the spared nerve injury model of neuropathic pain

    Bjerrum, Ole Jannik, 2005, In: European Journal of Pharmaceutical Sciences. 516, p. 131-138 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Characterization of drug combination effects in a rat model of neuropathic pain ny population modelling and simulation of response-time profiles

    Bjerrum, Ole Jannik & Honoré, P. G. H., 2011.

    Research output: Contribution to conferencePosterResearchpeer-review

  15. Published

    Co-administered gabapentin and venlafaxine in nerve injured rats: effect on mechanical hypersensitivity, motor function and pharmacokinetics

    Folkesson, A. J. M., Honoré, P. G. H. & Bjerrum, Ole Jannik, 2009, In: Scandinavian Journal of Pain. 1, 2, p. 91-97

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Combination therapy for neuropathic pain: Donepezil improves gabapentins antinoceptive effect in SNI rats

    Bjerrum, Ole Jannik & Honoré, P. G. H., 2011.

    Research output: Contribution to conferencePosterResearchpeer-review

  17. Published
  18. Published

    Community pharmacy driven pharmacovigilance

    Bjerrum, Ole Jannik & Christensen, S. T., 2010.

    Research output: Contribution to conferencePosterCommunication

  19. Published

    Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen) and phenobarbital in human volunteers

    Lappin, G., Shishikura, Y., Jochemsen, R., Weaver, R. J., Gesson, C., Houston, J. B., Oosterhuis, B., Bjerrum, Ole Jannik, Grynkiewicz, G., Alder, J., Rowland, M. & Garner, C., 20 Apr 2011, In: European Journal of Pharmaceutical Sciences. 43, 3, p. 141-150 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Decrease in nocifensive behaviour in rats after treatment with the EAAT-2 transporter inducer cetriaxone

    Bjerrum, Ole Jannik, Honoré, P. G. H. & Abrahamsen, B., 2011.

    Research output: Contribution to conferencePosterResearchpeer-review

  21. Published

    Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response Analysis

    Nøhr-Nielsen, A., Lange, Theis, Forman, Julie Lyng, Papathanasiou, T., Foster, D. J. R., Upton, R. N., Bjerrum, Ole Jannik & Lund, Trine Meldgaard, 2020, In: The AAPS Journal. 22, 2, 32.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Development of quantitative Pharmacology Pharmacometrics in Denmark

    Bjerrum, Ole Jannik & Honoré, P. G. H., 2011.

    Research output: Contribution to conferencePosterResearchpeer-review

  23. Published

    Development of quantitative pharmacology-pharmacometrics in Denmark

    Honoré, P. G. H., Bjerrum, Ole Jannik, Lund, Trine Meldgaard, Angelo, H., Ingwersen, S. H., Thygesen, P., Kristensen, K. & Larsen, F., 2011.

    Research output: Contribution to conferencePosterResearch

  24. Published

    Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain

    Hald, A., Ding, M., Egerod, Kristoffer Lihme, Hansen, R. R., Konradsen, D., Jørgensen, S. G., Atalay, B., Nasser, A., Bjerrum, Ole Jannik & Heegaard, Anne-Marie, 2008, In: Pharmacology, Biochemistry and Behavior. 91, 1, p. 38-46 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Donepezil anvendt ved neuropatisk smerte

    Bjerrum, Ole Jannik & Bjerrum, H. J., 2013, In: Ugesskrift for læger. 175, 42, p. 2493-2494 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 1302721